Page last updated: 2024-10-25

deferoxamine and Dermatitis

deferoxamine has been researched along with Dermatitis in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Dermatitis: Any inflammation of the skin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scott, C1
Bonner, J1
Min, D1
Boughton, P1
Stokes, R1
Cha, KM1
Walters, SN1
Maslowski, K1
Sierro, F1
Grey, ST1
Twigg, S1
McLennan, S1
Gunton, JE1

Other Studies

1 other study available for deferoxamine and Dermatitis

ArticleYear
Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing.
    American journal of physiology. Cell physiology, 2014, Aug-15, Volume: 307, Issue:4

    Topics: Aged; Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Case-Control Studies; Cells, Cultured

2014